Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A.
about
Computational multiscale toxicodynamic modeling of silver and carbon nanoparticle effects on mouse lung functionImmunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulationValue of phagocyte function screening for immunotoxicity of nanoparticles in vivoThe impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug deliveryPulmonary surfactant is indispensable in order to simulate the in vivo situationSurfactant protein A (SP-A) inhibits agglomeration and macrophage uptake of toxic amine modified nanoparticlesThe interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticlesPhysicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein coronaEffect of pulmonary surfactant on the dissolution, stability and uptake of zinc oxide nanowires by human respiratory epithelial cellsQuantification of gold nanoparticle cell uptake under controlled biological conditions and adequate resolution.Nanoparticles modulate surfactant protein A and D mediated protection against influenza A infection in vitro.Biokinetics of zinc oxide nanoparticles: toxicokinetics, biological fates, and protein interaction.Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and type-II epithelial cells.Biomimetic delivery with micro- and nanoparticlesInteraction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle.Chitosan-coated magnetic nanoparticles prepared in one step by reverse microemulsion precipitationComparison of cellular effects of starch-coated SPIONs and poly(lactic-co-glycolic acid) matrix nanoparticles on human monocytesPerturbation of physiological systems by nanoparticles.Upconverting nanoparticles: assessing the toxicity.Effect of particle agglomeration in nanotoxicology.Generation of tailored aerosols for inhalative drug delivery employing recent vibrating-mesh nebulizer systems.Evolution, Development, and Function of the Pulmonary Surfactant System in Normal and Perturbed Environments.In Vitro Investigation of Influences of Chitosan Nanoparticles on Fluorescein Permeation into Alveolar Macrophages.Particle uptake efficiency is significantly affected by type of capping agent and cell line.Metallic oxide nanoparticle translocation across the human bronchial epithelial barrier.The influence of natural pulmonary surfactant on the efficacy of siRNA-loaded dextran nanogels.Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.Toxicity of Nanoparticles on the Reproductive System in Animal Models: A Review.Nontoxic impact of PEG-coated gold nanospheres on functional pulmonary surfactant-secreting alveolar type II cells.Pulmonary surfactant protein SP-D opsonises carbon nanotubes and augments their phagocytosis and subsequent pro-inflammatory immune response.Protein corona: implications for nanoparticle interactions with pulmonary cells.Supported pulmonary surfactant bilayers on silica nanoparticles: formulation, stability and impact on lung epithelial cells.Nanoparticle-Cell Interactions: Relevance for Public Health.Development of novel fluorescent particles applicable for phagocytosis assays with human macrophages.The Role of Collectins and Galectins in Lung Innate Immune Defense
P2860
Q21559531-717681DF-C320-4361-82EE-405A24DCF255Q26825654-8A38749E-FF4E-4538-95D4-E5E104BD36ADQ28084932-EF105F1B-F175-406F-A179-3CE978BE8F15Q28085280-7A2D3E9F-4F1E-436C-82D7-2E606B776DF2Q28396472-90CA5508-645F-43E6-8012-846F851308D4Q28397412-E22A3BD4-7463-490D-A44A-B69CF9E78739Q28481207-E32FE913-2643-409C-A5A3-2182105F9FFBQ29248541-528A595A-68B3-444F-BC78-B71DD3FAEF5BQ29248847-159568D8-838C-4A06-81D4-601FBDA03390Q34759412-726E101D-ADF0-4D41-BF15-22112FEC366EQ34768820-37654163-8EDF-43CE-9FF3-90984E5189D1Q34787922-74EB1DAB-7B2A-4410-BF40-25C960A9675AQ36612289-ED561CDB-A24A-4DC4-BA12-AB23D63A249EQ36768786-7215103B-C467-4E1D-BCCB-DC15A402D633Q37037910-0CFB9C06-2C5E-442C-9589-90E89CE648CAQ37291155-44BE62FC-4E6A-4174-B771-5477A609F2B6Q37354257-908FDA6D-7B11-44DE-97BF-ECB431AAB95DQ38197488-48BC0195-A359-48AB-91A8-312534E923DDQ38245148-85AE84F0-1F59-430B-915D-48E874E0E357Q38331210-D2E45859-57F5-4627-AEE6-041D538FA1A2Q38498038-1A71F031-B945-4520-A03D-9EFA6712295AQ38693287-5798EEEB-DDA9-40D7-9CCF-813CA46DE398Q38788185-04A6594B-B888-4C05-9899-A5E456BBCF08Q38895074-D0C361D0-3C17-4EBA-BF96-18EACE728192Q38909164-57FAEAA0-3CB6-4BFC-BB50-780496124FFFQ39192476-6861DE01-6016-41CC-B287-49F8CE653AF4Q39393477-6DFF0277-B295-4ABC-BA64-4D2824243BC2Q41453466-40DEACCA-621E-4B19-A11A-B91828BADB30Q44594406-6F79442D-4348-4D51-B13D-D1BB19517DEEQ45049186-4C5B26D2-1240-48E9-AE03-E517E8E0A31EQ45305194-BF71EE5E-5854-4B62-8AFB-F55C04037097Q47760741-CAB62EB4-8435-4C7D-B7AD-50235896814DQ48351329-4CFDD9E3-1D62-43E3-A6A6-CE9CF45450CCQ49967408-7F56D751-6AC0-475A-A071-817BAFB9EE66Q58036012-7F9B2A32-BD8C-4003-88E1-21E71C7388DB
P2860
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A.
@en
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A.
@nl
type
label
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A.
@en
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A.
@nl
prefLabel
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A.
@en
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A.
@nl
P2093
P50
P1476
Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A.
@en
P2093
Christian A Ruge
Julian Kirch
Ulrich F Schaefer
P304
P356
10.1016/J.NANO.2011.07.009
P577
2011-08-10T00:00:00Z